Recent Headlines
Theravectys Launches Its New Website & Wins Deloitte’s Technology Fast50 "2014 Biotech d’Avenir" Award
A rewarding November for the promising French biotech: a prestigious prize & an impactful communication tool! Theravectys wins Deloitte Technology Fast 50 “2014 Biotech d’Avenir,” a prize awarded to one of the fastest-growing, most innovative & dynamic biotech company of the year. In addition, Theravectys is proud to announce the launch of its responsive and easy-to-navigate website www.theravectys.com featuring new sections & content. - December 18, 2014 - Theravectys
Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine; Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been featured in the December 15, 2014 issue of CEO/CFO Magazine in which ACT President and CEO Randall B. Riggs discusses PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. - December 17, 2014 - Advanced Cancer Therapeutics
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
ALPCO Releases New Chemiluminescent Human C-peptide ELISA
ALPCO adds to their STELLUX® Chemiluminescent line of assays with the launch of the new Human C-peptide ELISA. - December 10, 2014 - ALPCO
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
Fertility Preservation Network Sponsors 2014 Cancer Fundraiser Event Teams
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in multiple 2014 cancer research fundraisers. ReproTech, Ltd. sponsored its Reno, NV staff and team to participate in... - December 03, 2014 - ReproTech, LLC
MR Solutions Announces the First Installations of Its Second Generation Cryogen Free Magnet Technology for Increased Scientific Capabilities in Preclinical MRI
MR Solutions has introduced its second generation MRI magnet technology to its range of ground breaking 3T and 7T, cryogen free, preclinical scanners. Features of this new technology include variable field operation, higher intrinsic magnetic field homogeneity, larger fields of view (FOV)... - December 03, 2014 - MR Solutions
electroCore CEO, JP Errico, Emphasizes the Importance of Early Collaboration with Patients Group, Providers, and Payors When Introducing Innovative Technologies
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers... - November 28, 2014 - electroCore
Penthu Will be Officially Presented on 3rd of December 2014 in Basel
Europital has established a date for presenting its latest project: PenThu, a global platform developed by clinical research professionals for clinical research professionals. The event will take place next 3rd of December in Basel, concretely at the Radisson Blu Hotel, situated in the heart of... - November 27, 2014 - Europital BVBA
8.5K in Los Angeles Raises $33,000 for PBTF
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised $33,000 in Los Angeles on Nov. 22. The 8.5K event at Griffith Park honored local children with brain tumors. These Stars were Adam, Bella, Brittney, Caitlyn, Cassie,... - November 27, 2014 - Pediatric Brain Tumor Foundation
Advanced Cancer Therapeutics’ PFK-158 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been chosen by Informa and Kantar Health as one of the “2014 Top 10 Most Interesting Oncology Projects to Watch” for its compound, PFK-158. PFK-158 is a small... - November 27, 2014 - Advanced Cancer Therapeutics
Pipette.com Launches Its Seasonal Sale with Incredible Savings
Pipette.com announces their Black Friday Sale on pipettes, pipette tips, and lab equipment, it will help labs make the best out of their year-end budget. - November 27, 2014 - Pipette.com
NanoHybrids Publishes White Paper on "Make vs Buy" Gold Nanoparticles
“Should we try and make our own gold nanoparticles or buy them from a supplier?” This white paper approaches the question objectively to see which customers could benefit the most from buying gold nanoparticles instead of making them in house. - November 26, 2014 - NanoHybrids
Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014
Because of its previous success, Pipette.com is extending the Sartorius Entris Balance promotion. This is an ideal promotion for academic and smaller size independent laboratories. - November 22, 2014 - Pipette.com
Logos Biosystems to License “Clarity™” Technology from Stanford University
A novel tissue clearing technology allows researchers to obtain optically transparent and macromolecular permeable brain tissue. - November 21, 2014 - Logos Biosystems, Inc
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Student Discusses Fertility Preservation Options for Cancer Patients at Whitworth University
Whitworth University in Spokane, WA was the setting for a student presentation designed to educate and inform fellow students of the importance of fertility preservation for cancer patients. Kayla Batastini, daughter of ReproTech Site Director, Danika Batastini, and nursing student of Whitworth... - November 20, 2014 - ReproTech, LLC
i-calQ Receives U.S. Patent for Smartphone-Based Method of Rapid Diagnostic Testing
The first smartphone-based quantitative point-of-care diagnostic platform with integrated decision support. Turn any smartphone into a portable laboratory and medical specialist. - November 20, 2014 - i-calQ, LLC
Houston Runs to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised nearly $15,000 in Houston on Nov. 15. The 8.5K event at Discovery Green honored local children with brain tumors. These Stars were Mandy, Taylor, Tobin and... - November 20, 2014 - Pediatric Brain Tumor Foundation
DNAe Highlights the Urgent Need for Fast Diagnostics to Help Tackle the Growing Threat of Antibiotic Resistance
Welcomes £10 million Longitude Prize for an accurate, rapid, cost-effective and easy-to-use point-of-need diagnostic test for bacterial infections - November 20, 2014 - DNA Electronics
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Atlanta, San Francisco Top $100,000 for Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted 875 participants in Atlanta and San Francisco on Nov. 8. At start time, the events had raised $116,000. The crowds came to the 8.5K events at Centennial Olympic Park... - November 15, 2014 - Pediatric Brain Tumor Foundation
Jake Worthington to Perform at Starry Night Houston
Houston native Jake Worthington, a recent finalist on The Voice, will perform at Starry Night Houston on Saturday, Nov. 15 at Discovery Green. The Pediatric Brain Tumor Foundation’s Starry Night 8.5K is an evening walk/run that shines a light on kids battling one of the deadliest forms of... - November 15, 2014 - Pediatric Brain Tumor Foundation
Maternity Test Now Available at TestDiagnostics.com
TestDiagnostics is proud to offer the maternity DNA testing kit. Testing situations are not fun for anyone, and they understand the delicate nature of DNA testing. To make the process smooth and easy for you, TestDiagnostics provides you with these tests for your convenience. When you have to take... - November 12, 2014 - Test Diagnostics Limited
Affinity Biologicals Inc. to Showcase their Factor Deficient Plasmas for Hemostasis & Thrombosis Research at the MEDICA 2014 in Düsseldorf, Germany
On November 12, 2014 through to November 15, 2015, Affinity Biologicals Inc. will be attending the annual MEDICA trade fair in Düsseldorf, Germany to showcase their line of factor deficient/ factor depleted plasmas. - November 11, 2014 - Affinity Biologicals
Affinity Biologicals Inc. Launches Their Debut VisuLize™ Factor VII Antigen – A Polyclonal Antibody Based ELISA Kit
As a licensed medical device manufacturer that is recognized by the US Food and Drug Administration, Health Canada, and European regulatory authorities, Affinity Biologicals Inc. is constantly striving to produce reliable reagents for various applications in the health science industry. - November 11, 2014 - Affinity Biologicals
Colorado BioScience Association Showcases Industry’s Best at 2014 Awards Dinner Celebration
Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s Virocyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award. - November 06, 2014 - Colorado BioScience Association
Pathology Diagnostics Ltd Publish First White Paper in Series - The Use of Immunohistochemistry in Biomarker Research and Clinical Trials
The white paper, "The Use of Immunohistochemistry in Biomarker Research and Clinical Trials" is to be the first of a series of white papers published by Pathology Diagnostics over the next six months. - November 04, 2014 - Pathology Diagnostics Ltd
Pipette.com Alleviates Lab Budget Cuts with BrandTech’s Plate and Multichannel Pipette Promotion
Pipette.com offers the Buy 1 BrandTech Transferpette S Multichannel Pipette and Get 1 Case of BRANDplates for Free. This promotion will benefit those seeking to replenish their plate inventory. - November 01, 2014 - Pipette.com
Europital Will be Present at BIO-Europe 2014
Europital will attend Europe's largest partnering conference serving the global biotechnology industry. - October 29, 2014 - Europital BVBA
Surgical Science Launches Complete Inter-Professional Education System, TeamSim™
Surgical Science, leading developer of virtual reality surgical simulation training systems, has announced the launch of TeamSim, a complete inter-professional education training system. Available today, this innovative new offering provides surgical teams with a faster, safer way to develop and... - October 26, 2014 - Surgical Science Inc
Europital Awarded the Development of PenThu to RapidValue
Europital BVBA have awarded the development of its pioneer platform for Medical Management in Clinical Trials, PenThu, to the Californian-based technology firm RapidValue. The first development steps of this innovative project started in May 2014. PenThu is planned to be publicly presented at the... - October 26, 2014 - Europital BVBA
ASAlaser at MEDICA 2014: Internationalization, Innovation and Growth
Meeting international distributors, building new partnerships and presenting the entire range of products: these are the main goals of the company on the eve of its 31st participation at the German fair (Düsseldorf, 12-15, November 2014). The exhibition will also be the occasion to give visibility to the new corporate image. - October 26, 2014 - ASA srl
Trial Reported in Headache and Pain Journal Further Confirms the Effectiveness of electroCore’s Non-Invasive Vagus Nerve Stimulation Treatment for Headache
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4%... - October 25, 2014 - electroCore
NanoHybrids Receives Funding to Develop Molecular Imaging Agent for Atherosclerosis
NanoHybrids, Inc., an Austin-based, emerging biotech company developing nanotechnology-based clinical and pre-clinical solutions, was recently awarded a Small Business Innovation Research (SBIR) contract grant to develop a targeted biocompatible imaging contrast agent that will help detect high risk atherosclerotic plaques. - October 25, 2014 - NanoHybrids
Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing
Pipette.com has added the Sartorius CPA Semi-Micro Balance to their portfolio. This introductory price is only for a limited time and will benefit lab technicians looking for a dependable and durable laboratory balance. - October 24, 2014 - Pipette.com
Boston, Philadelphia Join Starry Night to Cure the Kids
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted more than 500 participants in Boston and Philadelphia on Oct. 18. At start time, the events had raised $61,000. The crowds came to the 8.5K events at Joe Moakley... - October 23, 2014 - Pediatric Brain Tumor Foundation
Colorado BioScience Association Announces Finalists for 2014 "Company of the Year" and "Rising Star" of the Year Awards
The Colorado BioScience Association (CBSA) has chosen the finalists for the 2014 “Company of the Year” and “Rising Star” Awards, which they will present during the Annual Awards Dinner held on Thursday, November 6, at the Marriott City Center, 1701 California Street, Denver,... - October 22, 2014 - Colorado BioScience Association
Fertility Preservation Options for Cancer Patients Discussed at Renown Cancer Center
Renown Cancer Institute in Reno, NV was the setting for a presentation designed to promote education and extend access to fertility preservation services. ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular... - October 22, 2014 - ReproTech, LLC
Colorado BioScience Association Honors Industry’s Best at 2014 Awards Dinner, Featuring Keynote by Olympic Medalist & Parkinson’s Survivor Davis Phinney
The Colorado BioScience Association (CBSA) will honor outstanding bioscience companies and individuals throughout the state at its Annual Awards Dinner, November 6, at the Denver Marriott City Center. This year’s event will feature keynote speaker Davis Phinney, Olympic medalist and cycling great who is successfully living with early-onset Parkinson’s disease and in 2004 founded the Colorado-based Davis Phinney Foundation. - October 20, 2014 - Colorado BioScience Association
Fertility Preservation Network Welcomes Spokane, Washington Area Facility
Program greatly extends access to Fertility Preservation services. - October 16, 2014 - ReproTech, LLC
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Calling All Future Nurses
The Right Solutions is offering three $500 scholarships to high school seniors and college students enrolled in a nursing program. - October 13, 2014 - The Right Solutions
Clinovo Sponsors the Genentech Annual Golf Tournament 2014 Fall Classic
Clinovo sponsors the Genentech Annual Golf Tournament 2014 Fall Classic at the Poppy Ridge Golf Course in Livermore, California on Friday, October 17, 2014. This year marks the fifth annual Genentech Charity Golf Tournament to support the fight against cancer. The Tournament is organized in memory... - October 13, 2014 - Clinovo
Zenascope Aids in the Screening and Detection of Cervical Cancer in Developing Countries
Zenalux Biomedical, Inc. presented its latest findings on the investigational use of the Zenascope® in cervical cancer screening at the U.S. Investigators’ Symposium on Global Non-Communicable Disease Research. The poster—titled “Towards a viable solution for a see and treat paradigm for cervical pre-cancer screening in East Africa”—focused on the use of the Zenascope in cervical pre-cancer screening in East Africa where neither HPV testing nor Pap smears are routinely available. - October 10, 2014 - Zenalux Biomedical, Inc.
Starry Night Chicago Raises Funds to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on childhood brain tumors, made its debut in Chicago on Oct. 4 with the support of more than 500 participants. At start time, the event had raised $46,000. The crowd came to the 8.5K at Arlington... - October 09, 2014 - Pediatric Brain Tumor Foundation
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
Colorado BioScience Association Promotes Colorado’s Medical Technology Industry, Along with Two of the State’s Economic Development Entities at AdvaMed 2014
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will tout Colorado’s growing medical device and diagnostic sectors during the '2014 AdvaMed: The MedTech Conference' in Chicago, IL, October 6-8. - October 08, 2014 - Colorado BioScience Association